Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Anaxagoras who wrote (1979)	1/22/1998 7:48:00 PM
From: Dr. Voodoo	Read Replies (1) \| Respond to of 7041

"...Zonagen's lead product candidate, Vasomax(TM), is an oral pill treatment for male erectile dysfunction. The company also is developing new approaches to contraception, including zona pellucida-based vaccines in collaboration with Schering AG...." Their seems to be a distinct separation between Vasomax(TM) and Schering AG. This is probably nothing, but I think it's a little creepy, like a few things that seem to get worded strange. I'm probably nuts. (Myron, you can chime in any time.) Rob